Novo sues Lilly, claiming misleading ads in weight-loss drug battle
LONDON, July 21 (Reuters) – Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday,…
Prenatal use of certain medications can harm developing fetal brain
A review article by a University of Nebraska Medical Center/Child Health Research Institute research team underscores and describes…
FDA Updates Nationwide Blood Pressure Drug Recall
Recent blood pressure medication recalls have occurred repeatedly for issues with how they dissolve, as the chemical composition…
10 Common Medications That Can Harm Your Eyes
All medications can cause side effects, but some can affect a part of your body you may not…
5 Retatrutide Side Effects: What We Know From Clinical Trials
Key takeaways Retatrutide is an injectable weight loss drug currently in development. It’s an investigational drug that’s not…
Troubling Findings in Study of GLP-1 Compounders
Shortages of the GLP-1 receptor agonists tirzepatide and semaglutide resolved in December 2024 and February 2025, respectively.A secret…
Unused medicines costing Jersey £500k a year – government
The amount of unused medicines is estimated to be costing about £500,000 a year in Jersey, says the…
FDA Updates Nationwide Blood Pressure Drug Recall
Recent blood pressure medication recalls have occurred repeatedly for issues with how they dissolve, as the chemical composition…
Yukon gov’t working to add new cystic fibrosis medication to its drug plan
Listen to this article Estimated 3 minutes The audio version of this article is generated by AI-based technology.…
Colorado was the first state to cap a drug’s price – then a federal court stepped in
Colorado is one of a handful of states with a review board for drug prices and one of…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
Drug pricing deadlock stalls hundreds of new medicines, strands investment
Hundreds of new medicines remain stuck without pricing approval, leaving patients waiting while companies see investments frozen 20…